Publications:
A selected list of publications:
Sadeghi S, Marder VJ, Stewart D, Kong M, Humphries J, Baumbach GA, Jesmok G.
"Safety of Plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleedin",
J Thromb Haemost. ,
2003; 1(12):
2621-5.
Levine AM, Sadeghi S, Espina BM, Tulpule A, Mochamuk R, Chen J, Nathwani B.
Characteristics of low-grade non-hodgkin's lymphoma in patients with infection by human immunodeficiency virus (HIV) Type 1. Abstracts of the 2001 International AIDS Malignancy Conference. Bethesda, Maryland, April 23-25,
,
2001;
Abstract #61.
Arzoo K, Sadeghi S, Liebman HA.
Remission Induced by Rituximab in Autoimmune Disorders. Abstracts of the 44th Annual Meeting of the American Society of Hematology. Philadelphia, Pennsylvania, December 7-11,
,
2001;
Abstract #3723.
Grovit-Ferbas K, Ferbas J, Sadeghi S, Kaplan A, Giorgi J, Chen ISY, O'Brien WA.
Characterization of an attenuated strain of HIV-1 from a long-term survivor. Abstracts of the Keystone Symposia,
,
1997;
.
Grovit-Ferbas K, Ferbas J, Gudeman V, Sadeghi S, Goetz MB, Giorgi JV, Chen ISY, O'Brien WA.
Potential contributions of viral envelope and host genetic factors in an HIV-1 long-term survivor. Abstracts of the 1997 Palm Springs Symposium on AIDS,
,
1997;
.
O'Brien WA, Sumner-Smith M, Mao S-H, Sadeghi S, Zhao J-Q, Chen ISY.
"Anti-HIV-1 activity of an oligocationic compound is mediated via gp120 V3 interactions",
J Virol,
1996; 70:
2825-2831.
For artwork in: O'Brien WA and Pomerantz RJ.
AIDS and other diseases due to HIV infection,
Viral Pathogenesis,
1996; (Nathanson N (ed)):
.
Grovit-Ferbas K, Sadeghi S, Goodman V, O'Brien WA, Giorgi J, Chen ISY.
HIV-1 envelope as a correlate of delayed progression to AIDS. Abstracts of the 5th UCLA AIDS Institute Symposium, Los Angeles, CA,
,
1996;
.
Grovit-Ferbas K, Sadeghi S, Ferbas J, Parekh A, Kaplan A, Giorgi J, O'Brien WA.
HIV-1 envelope as a correlate of delayed progression to AIDS. Abstracts of the XIth International Conference on AIDS, Vancouver, B.C., Canada,
,
1996;
.
O'Brien WA, Hartigan P, Sadeghi S, Hamilton J.
Clinical Benefit of Zidovudine therapy can be predicted by early plasma HIV-1 RNA response. Abstracts of the 1995 UCLA/UCI AIDS Symposium, Mechanisms of HIV Disease, Palm Springs, CA,
,
1995;
.
Sadeghi S, Khaw M, Namazi A, Parekh A, O'Brien WA.
HIV-1 integration is necessary for the productive infection of mononuclear phagocytes. Abstracts of the Annual UCLA AIDS Institute Symposium: Molecular Pathogenesis and Immunobiology of HIV-1, Los Angeles, CA,
,
1994;
p.27.
For artwork in: O'Brien WA, Mao S-H, Cao Y, Moore JP.
Macrophages and T-cell tropic HIV-1 strains differ in their susceptibility to neutralization by soluble CD4 at different temperatures,
J Virol,
1994; 68:
5264-5269.
O'Brien WA, Hartigan P, McCreedy B, Sadeghi S, Hamilton JD.
Predictive value of plasma HIV-1 RNA and I22 microglobulin in determining clinical outcome. Inter-Science Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL,
,
1994;
(Abstract 1208).
Kalhor HR, Durmaz R, Parekh A, Sadeghi S, Hamilton JD, O' Brien WA, and the VA Cooperation Study Group.
The molecular basis of AZT resistance associated with clinical progression in treated patients. Abstracts of the 1994 UCLA/UCI AIDS Symposium: Novel Therapies for HIV/AIDS, Palm Springs, CA,
,
1994;
p.23.
Parekh A, Durmaz R, Kalhor HR, Sadeghi S, Hamilton JD, O'Brien WA, and the VA Cooperative Study Group.
The molecular basis of AZT resistance associated with clinical progression in treated patients. Abstracts of the Annual UCLA AIDS Institute Symposium: Molecular Pathogenesis and Immunobiology of HIV-1, Los Angeles, CA,
,
1994;
p.27.
O'Brien WA, Mao S-H, Sadeghi S, Sumner-Smith M, Chen ISY.
Abstracts of the 2nd UCLA AIDS Institute Symposium: Novel Anti-HIV Therapies-From Bench to Clinic, West Hollywood, CA,
,
1993;
p.17.
